1. Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial. Issue 10064 (7th January 2017) Authors: Balar, Arjun V; Galsky, Matthew D; Rosenberg, Jonathan E; Powles, Thomas; Petrylak, Daniel P; Bellmunt, Joaquim; Loriot, Yohann; Necchi, Andrea; Hoffman-Censits, Jean; Perez-Gracia, Jose Luis; Dawson, Nancy A; van der Heijden, Michiel S; Dreicer, Robert; Srinivas, Sandy; Retz, Margitta M; Joseph,... Journal: Lancet Issue: Volume 389:Issue 10064(2017) Page Start: 67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study. Issue 7 (July 2021) Authors: Lee, Chung-Han; Shah, Amishi Yogesh; Rasco, Drew; Rao, Arpit; Taylor, Matthew H; Di Simone, Christopher; Hsieh, James J; Pinto, Alvaro; Shaffer, David R; Girones Sarrio, Regina; Cohn, Allen Lee; Vogelzang, Nicholas J; Bilen, Mehmet Asim; Gunnestad Ribe, Sara; Goksel, Musaberk; Tennøe, Øyvind Kroh... Journal: Lancet oncology Issue: Volume 22:Issue 7(2021) Page Start: 946 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Nivolumab plus rucaparib for metastatic castration-resistant prostate cancer: results from the phase 2 CheckMate 9KD trial. Issue 8 (17th August 2022) Authors: Fizazi, Karim; Retz, Margitta; Petrylak, Daniel P; Goh, Jeffrey C; Perez-Gracia, Jose; Lacombe, Louis; Zschäbitz, Stefanie; Burotto, Mauricio; Mahammedi, Hakim; Gravis, Gwenaelle; Bastos, Diogo Assed; McCune, Steven L; Vázquez Limón, Juan Carlos; Kwan, Edmond M; Castellano, Daniel; Fléchon, Aude;... Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 8(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗